Long-term botulinum toxin treatment of cervical dystonia- EMG changes in injected and noninjected muscles
Erdal J, Ostergaard L, Fuglsang-Frederiksen A, et al. Long-term botulinum toxin treatment of cervical dystonia- EMG changes in injected and noninjected muscles. Clin Neurophysiol 1999;110:1650-4.
Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance
Rollnik JD, Matzke M, Wohlfarth K, et al. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. Eur Neurol 2000;43:9-12.
Botulinum toxin injection for spasmodic torticollis: Increased magnitude of benefit with electromyographic assistance
Comella CL, Buchman AS, Tanner CM, et al. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992;42:878-82.
Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin
Fuglsang-Frederiksen A, Ostergaard L, Sjo O, et al. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin. Electromyogr Clin Neurophysiol 1998;38:75-9.
Evaluating the role of botulinum toxin in the management of focal hypertonia in adults
Richardson D, Sheean G, Werring D, et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 2000;69:499-506.
Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle
Dressler D, Rothwell JC. Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle. Eur Neurol 2000;43:13-6.